A detailed history of Brevan Howard Capital Management LP transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 73,626 shares of SANA stock, worth $221,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,626
Holding current value
$221,614
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.6 - $4.36 $117,801 - $321,009
73,626 New
73,626 $120,000
Q2 2024

Aug 14, 2024

BUY
$5.23 - $10.44 $242,128 - $483,330
46,296 New
46,296 $252,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $573M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.